Gerald Pier

Gründer bei ALOPEXX, INC.

74 Jahre

Consumer Services

Health Technology

Profil

Gerald B. Pier is the founder of Alopexx, Inc., founded in 2006, holding the title of Director & Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Dr. Pier currently holds the position of Professor at Harvard Medical School.
Dr. Pier earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of the Pacific.

Aktive Positionen von Gerald Pier

Unternehmen	Position	Beginn
ALOPEXX, INC.	Gründer	01.01.2006
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies	Gründer	-

Alle aktiven Positionen von Gerald Pier

Ausbildung von Gerald Pier

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Gerald Pier im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of the Pacific University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies	Health Technology
Alopexx, Inc. Alopexx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops novel and broad-spectrum immune-mediated therapeutics	Health Technology